Secondary Prophylaxis in Patients Who Have Experienced Portal Hypertensive Bleeding
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Papatheodoridis G, Goulis J, Leandro G, Patch D, Burroughs A
. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology. 1999; 30(3):612-22.
DOI: 10.1002/hep.510300316.
View
2.
DAmico G, Pagliaro L, Bosch J
. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 2000; 19(4):475-505.
DOI: 10.1055/s-2007-1007133.
View
3.
Lo G, Lai K, Cheng J, Chen M, Huang H, Hsu P
. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000; 32(3):461-5.
DOI: 10.1053/jhep.2000.16236.
View
4.
Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X
. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med. 2001; 345(9):647-55.
DOI: 10.1056/NEJMoa003223.
View
5.
Escorsell A, Banares R, Garcia-Pagan J, Gilabert R, Moitinho E, Piqueras B
. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology. 2002; 35(2):385-92.
DOI: 10.1053/jhep.2002.30418.
View